Bluejay Diagnostics, Inc. (BJDX) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Bluejay Diagnostics, Inc. (BJDX) Bundle
Whether you're an investor or analyst, this (BJDX) DCF Calculator is your go-to tool for accurate valuation. Preloaded with real data from Bluejay Diagnostics, Inc., you can adjust forecasts and observe the effects in real-time.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .2 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | -100 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -1.5 | -1.0 | -3.1 | -9.0 | -9.2 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | -3610.09 | 100 | 60 | 60 | 60 | 60 | 60 |
| Depreciation | .1 | .2 | .1 | .3 | .8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 123.02 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -1.6 | -1.2 | -3.2 | -9.3 | -10.0 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | -3733.11 | 100 | 60 | 60 | 60 | 60 | 60 |
| Total Cash | .1 | .9 | 19.0 | 10.1 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 0 | 100 | 80 | 80 | 80 | 80 | 80 |
| Inventories | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 0 | 100 | 80 | 80 | 80 | 80 | 80 |
| Accounts Payable | .0 | .4 | .3 | .6 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 255.31 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | -1.2 | -.7 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | -481.56 | 100 | -20 | -20 | -20 | -20 | -20 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -1.5 | -1.2 | -3.5 | -9.2 | -10.0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.5 | -.6 | -3.3 | -9.8 | -10.0 | -.5 | .0 | .0 | .0 | .0 |
| WACC, % | 6.32 | 6.41 | 6.46 | 6.44 | 6.46 | 6.42 | 6.42 | 6.42 | 6.42 | 6.42 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -2 | |||||||||
| Equity Value | 1 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | 10.17 |
What You Will Get
- Real BJDX Financials: Access detailed historical and projected data for precise valuation.
- Customizable Inputs: Adjust parameters such as WACC, tax rates, revenue growth, and capital expenditures.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Bluejay Diagnostics' future performance.
- User-Friendly Design: Designed for industry experts while remaining approachable for newcomers.
Key Features
- Pre-Loaded Data: Bluejay Diagnostics, Inc.'s (BJDX) historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: Observe BJDX's intrinsic value recalculating in real time.
- Clear Visual Outputs: Dashboard charts illustrate valuation results and key metrics effectively.
- Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.
How It Works
- Download: Obtain the pre-formatted Excel file containing Bluejay Diagnostics, Inc.'s (BJDX) financial data.
- Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various projections and instantly compare results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose Bluejay Diagnostics, Inc. (BJDX)?
- Innovative Solutions: Cutting-edge diagnostic technologies that enhance patient care.
- Proven Reliability: Backed by rigorous research and validated results for accurate diagnostics.
- Customizable Options: Flexible diagnostic tools tailored to meet diverse healthcare needs.
- User-Friendly Interface: Intuitive design ensures easy navigation and efficient use.
- Endorsed by Professionals: Trusted by healthcare experts for its precision and effectiveness.
Who Should Use This Product?
- Healthcare Professionals: Utilize advanced diagnostic tools to enhance patient care.
- Researchers: Integrate innovative diagnostic methodologies into studies and publications.
- Investors: Evaluate your investment strategies and assess the market potential of Bluejay Diagnostics, Inc. (BJDX).
- Analysts: Optimize your analysis process with a tailored, user-friendly diagnostic model.
- Medical Institutions: Understand how emerging companies like Bluejay Diagnostics, Inc. (BJDX) are transforming the healthcare landscape.
What the Template Contains
- Historical Data: Includes Bluejay Diagnostics, Inc.'s (BJDX) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Bluejay Diagnostics, Inc.'s (BJDX) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Bluejay Diagnostics, Inc.'s (BJDX) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.